(One intermediate revision by one other user not shown) | |||
Line 816: | Line 816: | ||
<h6>Part/Contribution</h6> | <h6>Part/Contribution</h6> | ||
<ul> | <ul> | ||
− | <li>We submitted and further characterised KillerRed (<a href="http://parts.igem.org/Part:BBa_K1914002"> | + | <li>We submitted and further characterised KillerRed (<a href="http://parts.igem.org/Part:BBa_K1914002">BBa_K1914002</a>).</li> |
<br /> | <br /> | ||
− | <li>We submitted KillerOrange phototoxic protein kill switch and provided extensive characterisation (<a href="http://parts.igem.org/Part:BBa_K1914000"> | + | <li>We submitted KillerOrange phototoxic protein kill switch and provided extensive characterisation (<a href="http://parts.igem.org/Part:BBa_K1914000">BBa_K1914000</a>).</li> |
<br /> | <br /> | ||
<li>We designed a codon optimised Lysozyme C Biobrick which targets the enzyme to the periplasm where it is most effective. | <li>We designed a codon optimised Lysozyme C Biobrick which targets the enzyme to the periplasm where it is most effective. | ||
− | (<a href="http://parts.igem.org/Part:BBa_K1914004"> | + | (<a href="http://parts.igem.org/Part:BBa_K1914004">BBa_K1914004</a>)</li>. |
</ul> | </ul> | ||
<h2 style="color:#757575; text-decoration: underline;" >Silver</h2> | <h2 style="color:#757575; text-decoration: underline;" >Silver</h2> | ||
Line 848: | Line 848: | ||
<h6>Human Practices</h6> | <h6>Human Practices</h6> | ||
<ul> | <ul> | ||
− | <li>We performed research on <a href="https://2016.igem.org/Team:Exeter/Integrated_Practices | + | <li>We performed research on <a href="https://2016.igem.org/Team:Exeter/Integrated_Practices/ED"> |
equality and diversity</a> in science, using the University of Exeter as a case study.</li> | equality and diversity</a> in science, using the University of Exeter as a case study.</li> | ||
<br /><li>We have created and tested an <a href="https://2016.igem.org/Team:Exeter/Engagement#section_1"> | <br /><li>We have created and tested an <a href="https://2016.igem.org/Team:Exeter/Engagement#section_1"> | ||
Line 862: | Line 862: | ||
<br /><li>Interviews with prominent academics, like | <br /><li>Interviews with prominent academics, like | ||
<a href="https://2016.igem.org/Team:Exeter/Engagement#section_6">Prof. Richard Dawkins</a> and | <a href="https://2016.igem.org/Team:Exeter/Engagement#section_6">Prof. Richard Dawkins</a> and | ||
− | <a href="https://2016.igem.org/Team:Exeter/Integrated_Practices# | + | <a href="https://2016.igem.org/Team:Exeter/Integrated_Practices/lab#section_2">Prof. Richard |
Titball</a> about their thoughts on public engagement and the importance of Biosafety, | Titball</a> about their thoughts on public engagement and the importance of Biosafety, | ||
respectively.</li> | respectively.</li> |
Latest revision as of 03:05, 20 October 2016